| Financial Year |
March 31 2023 |
| Monetary Funds |
12,057,089,203.32 |
| Held-for-trading Financial Assets |
131,850,045.00 |
| Notes Receivable |
76,823,966.07 |
| Accounts Receivable |
10,322,559,665.80 |
| Advances to Suppliers |
546,570,754.84 |
| Other Receivables |
450,774,513.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
53,771,631.92 |
| Inventories |
1,254,495,298.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
556,680,838.34 |
| Total Current Assets |
25,520,107,432.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,337,172,537.55 |
| Long-term Equity Investment |
9,853,151,550.49 |
| Investment Properties |
113,026,975.77 |
| Fixed Assetes |
193,616,177,252.08 |
| Under-construction Projects |
13,582,275,984.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,757,979,030.41 |
| R&D expenses |
13,698,377.99 |
| Goodwill |
118,397,605.35 |
| Long-Term Deferred and Prepaid Expenses |
133,927,385.07 |
| Deferred Income Tax Assets |
1,026,592,928.84 |
| Other Non-Current Assets |
5,572,048,143.44 |
| Sub-Total of Non-Current Assets |
236,008,063,787.34 |
| Total Assets |
261,528,171,219.58 |
| Short-Term Loans |
8,707,747,030.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
894,860,776.62 |
| Accounts Payable |
3,735,968,711.81 |
| Accounts Received In Advance |
7,712,687.74 |
| Employee Compensation Payable |
184,839,408.20 |
| Taxes Payable |
1,542,066,809.28 |
| Interest Payable |
-- |
| Dividend Payable |
103,101,096.19 |
| Other payables |
15,738,127,996.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,979,462,609.27 |
| Other Current Liabilities |
1,552,818.72 |
| Sub-Total of Current Liabilities |
38,802,848,395.88 |
| Long-term Loans |
112,827,556,561.02 |
| Bonds Payable |
10,839,324,823.33 |
| Long-Term Accounts Payable |
473,910,852.86 |
| Special Payable |
-- |
| Estimatied Liabilities |
23,627,927.95 |
| Deferred Income Tax Liabilities |
510,448,497.84 |
| Other Non-Current Liabilities |
376,717,834.48 |
| Sub-Total of Non-Current Liabilities |
126,025,210,569.53 |
| Total Liabilities |
164,828,058,965.41 |
| Paid-In Capital(Or Share Stock) |
7,454,179,797.00 |
| Capital Surplus |
10,948,527,549.43 |
| Surplus Reserve |
3,085,238,716.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
28,389,464,984.33 |
| Minority Stockholder's Interest |
40,534,281,404.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
56,165,830,850.08 |
| Owner's Equity（Stockholder's Equity） |
96,700,112,254.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
261,528,171,219.58 |
